| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
52,725 |
42,835 |
$2.88M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
6,028 |
5,324 |
$411K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
5,978 |
5,041 |
$401K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,392 |
2,844 |
$259K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,198 |
1,920 |
$145K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
3,554 |
2,844 |
$99K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
11,866 |
10,636 |
$92K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
7,523 |
3,245 |
$88K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,328 |
1,007 |
$82K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
6,528 |
5,665 |
$77K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
2,327 |
1,972 |
$72K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
872 |
742 |
$62K |
| 90670 |
|
3,145 |
2,894 |
$61K |
| 92551 |
|
6,182 |
5,370 |
$52K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,674 |
1,128 |
$51K |
| 99188 |
|
2,175 |
2,054 |
$43K |
| 90686 |
|
3,254 |
2,924 |
$34K |
| 99177 |
|
8,563 |
7,689 |
$31K |
| 90723 |
|
2,071 |
1,914 |
$28K |
| 87634 |
|
646 |
390 |
$24K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
3,137 |
2,417 |
$21K |
| 90648 |
|
1,883 |
1,772 |
$19K |
| 87807 |
|
1,326 |
1,126 |
$14K |
| 90633 |
|
1,072 |
962 |
$12K |
| 99173 |
|
5,278 |
4,648 |
$11K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
10,175 |
9,026 |
$11K |
| 90681 |
|
638 |
586 |
$10K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
654 |
525 |
$8K |
| 90651 |
|
233 |
201 |
$8K |
| 85018 |
|
3,697 |
3,160 |
$7K |
| 90647 |
|
761 |
647 |
$7K |
| 87081 |
|
1,138 |
1,060 |
$7K |
| 83655 |
|
680 |
575 |
$6K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
799 |
728 |
$6K |
| 90461 |
|
5,824 |
5,143 |
$6K |
| 99000 |
|
5,986 |
4,852 |
$6K |
| 99381 |
|
62 |
52 |
$4K |
| 90710 |
|
126 |
113 |
$4K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
102 |
96 |
$3K |
| 81003 |
|
1,474 |
1,140 |
$3K |
| 99051 |
|
1,067 |
992 |
$2K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
110 |
102 |
$2K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
119 |
102 |
$2K |
| 87428 |
|
86 |
57 |
$2K |
| 90696 |
|
108 |
96 |
$2K |
| 36416 |
|
7,512 |
6,166 |
$2K |
| 96127 |
|
310 |
287 |
$2K |
| 90734 |
|
109 |
96 |
$2K |
| 80061 |
Lipid panel |
127 |
107 |
$1K |
| 94760 |
|
2,332 |
2,098 |
$1K |
| 36415 |
Collection of venous blood by venipuncture |
485 |
376 |
$1K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
13 |
12 |
$850.82 |
| 96161 |
|
371 |
317 |
$671.46 |
| 90707 |
|
40 |
37 |
$525.53 |
| 90716 |
|
28 |
25 |
$376.67 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
15 |
13 |
$197.88 |
| 90700 |
|
13 |
12 |
$154.78 |
| 86308 |
|
33 |
26 |
$127.58 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
15 |
15 |
$37.60 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
22 |
13 |
$29.19 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
56 |
52 |
$3.62 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
23 |
13 |
$0.34 |
| 36591 |
|
27 |
24 |
$0.00 |
| 94762 |
|
15 |
15 |
$0.00 |
| 91300 |
|
12 |
12 |
$0.00 |